Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications von Tzavara, Eleni T., Li, Dominic L., Moutsimilli, Larissa, Bisogno, Tiziana, Di Marzo, Vincenzo, Phebus, Lee A., Nomikos, George G., Giros, Bruno

Volltext

5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis von Ramadan, NM, Skljarevski, V, Phebus, LA, Johnson, KW

Volltext

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation von Johnson, KW, Nelson, DL, Dieckman, DK, Wainscott, DB, Lucaites, VL, Audia, JE, Owton, WM, Phebus, LA

Volltext

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease von Du, Yansheng, Ma, Zhizhong, Lin, Suizhen, Dodel, Richard C., Gao, Feng, Bales, Kelly R., Triarhou, Lazarose C., Chernet, Eyassu, Perry, Ken W., David L. G. Nelson, Luecke, Susan, Phebus, Lee A., Bymaster, Frank P., Paul, Steven M.

Volltext

Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples von Chernet, Eyassu, Martin, Laura J., Li, Dominic, Need, Anne B., Barth, Vanessa N., Rash, Karen S., Phebus, Lee A.

Volltext

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain von YASUNO, Fumihiko, BROWN, Amira K, GLADDING, Robert L, HONG, Jinsoo, HALLDIN, Christer, PIKE, Victor W, INNIS, Robert B, ZOGHBI, Sami S, KRUSHINSKI, Joseph H, CHERNET, Eyassu, TAUSCHER, Johannes, SCHAUS, John M, PHEBUS, Lee A, CHESTERFIELD, Amy K, FELDER, Christian C

Volltext

Selective seratonin 1F (5-HT 1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial von Goldstein, DJ, Roon, KI, Offen, WW, Ramadan, NM, Phebus, LA, Johnson, KW, Schaus, JM, Ferrari, MD

Volltext

LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine von Sang, CN, Ramadan, NM, Wallihan, RG, Chappell, AS, Freitag, FG, Smith, TR, Silberstein, SD, Johnson, KW, Phebus, LA, Bleakman, D, Ornstein, PL, Arnold, B, Tepper, SJ, Vandenhende, F

Volltext

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs von Phebus, L A, Johnson, K W, Stengel, P W, Lobb, K L, Nixon, J A, Hipskind, P A

Volltext

Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats : implications for bipolar disorder von SEAGER, Matthew A, BARTH, Vanessa N, PHEBUS, Lee A, RASMUSSEN, Kurt

Volltext

The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats von NEED, Anne B, DAVIS, Richard J, ALEXANDER-CHACKO, Jesline T, EASTWOOD, Brian, CHERNET, Eyassu, PHEBUS, Lee A, SINDELAR, Dana K, NOMIKOS, George G

Volltext

Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat : correlation with the cytotoxic potential of H2O2 in vitro von HYSLOP, P. A, ZHIYUAN ZHANG, PEARSON, D. V, PHEBUS, L. A

Volltext

Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity von Seager, Matthew A, Huff, Keith D, Barth, Vanessa N, Phebus, Lee A, Rasmussen, Kurt

Volltext

Lanepitant, an NK-1 Antagonist, in Migraine Prevention von Goldstein, DJ, Offen, WW, Klein, EG, Phebus, LA, Hipskind, P, Johnson, KW, Ryan, RE

Volltext

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs von Johnson, Kirk W, Schaus, John M, Durkin, Margaret M, Audia, James E, Kaldor, Stephen W, Flaugh, Michael E, Adham, Nika, Zgombick, John M, Cohen, Marlene L, Branchek, Theresa A, Phebus, Lee A

Volltext

Ethyl (3S,4aR,6S,8aR)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester:  A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Mo... von Filla, Sandra A, Winter, Mark A, Johnson, Kirk W, Bleakman, David, Bell, Michael G, Bleisch, Thomas J, Castaño, Ana M, Clemens-Smith, Amy, del Prado, Miriam, Dieckman, Donna K, Dominguez, Esteban, Escribano, Ana, Ho, Ken H, Hudziak, Kevin J, Katofiasc, Mary A, Martinez-Perez, Jose A, Mateo, Ana, Mathes, Brian M, Mattiuz, Edward L, Ogden, Ann Marie L, Phebus, Lee A, Stack, Douglas R, Stratford, Robert E, Ornstein, Paul L

Volltext

Novel Potent 5-HT1F Receptor Agonists:  Structure−Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides von Filla, Sandra A, Mathes, Brian M, Johnson, Kirk W, Phebus, Lee A, Cohen, Marlene L, Nelson, David L, Zgombick, John M, Erickson, Jon A, Schenck, Kathryn W, Wainscott, David B, Branchek, Theresa A, Schaus, John M

Volltext

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of m... von Phebus, L A, Johnson, K W, Zgombick, J M, Gilbert, P J, Van Belle, K, Mancuso, V, Nelson, D L, Calligaro, D O, Kiefer, Jr, A D, Branchek, T A, Flaugh, M E

Volltext

The PET radioligand [ 11 C]MePPEP binds reversibly and with high specific signal to cannabinoid CB 1 receptors in nonhuman primate brain von Yasuno, F, Brown, AK, Zoghbi, SS, Krushinski, JH, Chernet, E, Tauscher, J, Schaus, JM, Phebus, LA, Chesterfield, AK, Felder, CC

Volltext

N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide:  A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine Therapy von Xu, Yao-Chang, Johnson, Kirk W, Phebus, Lee A, Cohen, Marlene, Nelson, David L, Schenck, Kathy, Walker, Clint D, Fritz, James E, Kaldor, Stephen W, LeTourneau, Michael E, Murff, Robert E, Zgombick, John M, Calligaro, David O, Audia, James E, Schaus, John M

Volltext